From LifeSiteNews.com…
Japanese conglomerate and pharmaceuticals company Kowa found that ivermectin has an “antiviral effect” against the Omicron strain of coronavirus, the company announced Monday.
In a press release, Kowa said that the renowned anti-parasitic drug shows antiviral properties in a lab setting against the new variant and all other existing strains of the virus, including Alpha, Beta, Gamma, and Delta.
Researchers previously found that ivermectin inhibits replication and intracellular entry of coronavirus in laboratory studies, Kowa noted. The company added that it expects the drug to be applied as a therapeutic for all new coronavirus diseases.
